Remdesivir Allocation

• Oregon’s Federal Redesivir Allocation: Patient Criteria and Hospital Distribution
• Hospital Agreement Form
• Last Mile Delivery User Guide for Shipping Remdesivir from OHA to Hospitals
• Fact Sheet for Health Care Providers: EUA of Remdesivir
• For patients:
  • Remdesivir Use for COVID-19 in Oregon – FAQ available in multiple languages
  • Fact Sheet for Patients and Parent/Caregivers – EUA of Remdesivir For Coronavirus Disease
    • Spanish Fact Sheet

COVID-19 Testing

Testing Guidance

• OHA Guidance for Clinicians Regarding COVID-19 Testing 
• Criteria for COVID-19 Testing at the Oregon State Public Health Laboratory 
• Ordering and Reporting COVID-19 Laboratory Tests 
• Guidelines for Emergency Testing Authorization for Oregon CLIA Certified Laboratories 

NOTE: Clinicians throughout the community can order COVID-19 testing at their discretion through commercial labs WITHOUT approval by public health.

To Get Approval for Testing through the Oregon State Public Health Laboratory

• Use the Confidential Oregon Morbidity Report form to request testing through OSPHL.
• How To Submit Online Morbidity Reports for COVID-19 
• OHA Guidance for Clinicians Regarding COVID-19 Testing

Clinical and Infection Control Guidance

Guidance for Clinics and Hospitals

• OHA Provisional Guidance: Clinical Care and Healthcare Infection Prevention and Control for COVID-19 
• Oregon Guidance for Healthcare Personnel on Use of PPE in Resource-Constrained Settings 
• CDC: Clinical Care Guidance
• CDC: Inpatient Obstetric Guidance

Guidance for Long-Term Care Facilities

• Long-Term Care Facility Response Toolkit
• COVID-19 Prevention and Response in Long-Term Care – Webinar Slides 
• CDC: Strategies to Prevent the Spread of COVID-19 in Long-Term Care Facilities
• Infection Control Consultation Request Form

Guidance for Home Care

• CDC: Implementing Home Care of People Not Requiring Hospitalization
• CDC: Preventing COVID-19 from Spreading in Homes and Communities
• CDC: Disposition of Non-Hospitalized Patients with COVID-19

Guidance for in-person interpreters and health care providers who work with them

• COVID-19 infection control guidance for in-person interpreters and health care providers who work with them 

Guidance for Correctional and Detention Facilities

• Interim Guidance on Management of Coronavirus Disease 2019 (COVID-19) in Correctional and Detention Facilities 

Entry into Acute Health Care Facilities

• Guidance for Entry into Acute Health Care Facilities 
  • Español / Spanish

Elective and Non-Urgent Procedures

Governor’s Executive Order 20-22

Framework for Restarting

• Framework for Restarting Non-Emergent and Elective Procedures in Hospitals and Ambulatory Surgical Centers 
• Framework for Restarting Non-Emergent and Elective Procedures in Medical and Dental Offices 

Guidance on Resumption of Non-Emergent and Elective Procedures

• Guidance for Hospitals Updated 5/29/2020
  • Complete and save the Hospital Attestation Form and submit online here.
• Guidance for Ambulatory Surgical Centers 
  • Complete and save the Ambulatory Surgical Center Attestation Form and submit online here.
• Guidance for Medical and Dental Offices, and Other Health Care Settings
• FAQ about this Guidance 

Clients with Suicide Risk

• Telehealth Tips: Clients with Suicide Risk

Non-discrimination in Medical Treatment

• Treatment Guidelines Relating to Non-Discrimination in Medical Treatment for COVID-19
  • Español / Spanish

Emergency Disease Reporting Rules

• COVID-19 Emergency Disease Reporting Rules

Submitting Specimens to OSPHL

Obtain approval for testing through the Oregon State Public Health Laboratory by submitting a Confidential Oregon Morbidity Report (see Provisional Guidance for details).

Specimens approved for testing should be shipped refrigerated (2-8°C) to the Oregon State Public Health Laboratory (OSPHL) following appropriate shipping regulations.

The following completed form must accompany all specimens:

• Virology/Immunology Test Request Form (one form per specimen)
  • In the “OTHER/MOLECULAR” section, mark the checkbox indicating “Other” and type or write in “2019-nCoV” or “COVID-19” on the line provided.

Please refer to the OSPHL Lab Test Menu and the CDC Interim Guidance for Collecting, Handling, and Testing Clinical Specimens from PUIs for complete specimen collection guidance.

COVID-19 Training: TRAIN Learning Network

CDC TRAIN provides access to courses developed by the Centers for Disease Control and Prevention (CDC) programs, grantees, and other funded partners. Courses offered by CDC course providers have been approved and verified by CDC.

• COVID-19 Courses in TRAIN